- What's Tisch?
- Stem Cell Trial
- Get Involved
Tisch MSRCNY research scientist Dr. Roberto Alfonso has been featured on an episode of Real Talk MS podcast about our recent research paper around COVID-19 vaccines, on which he was the lead author and which was published in the journal Frontiers in Immunology. This study’s findings – which showed strong T-cell activation following vaccination for COVID-19 among MS patients receiving anti-CD20 therapies – are significant as researchers continue to enhance their understanding of how MS patients, and other immunocompromised individuals, react to the COVID vaccines. In his interview with Real Talk MS, Dr. Alfonso highlighted that the results suggest that MS patients displayed a T-cell immune response to the COVID vaccines that is equal to, or even higher than, that of healthy controls.
You can listen to the full podcast here on the RealTalk MS website.